NCT07465757
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07465757
Title A Study of Alisertib and Paclitaxel in Patients With Small Cell Lung Cancer (SCLC) (ALISCA-Lung2)
Acronym ALISCA-Lung2
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Puma Biotechnology, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | ESP

Facility Status City State Zip Country Details
Cancer Care Specialists RECRUITING Reno Nevada 89511 United States Details
Institut Curie Paris RECRUITING Paris France Details
Hospital General Universitario Dr. Balmis RECRUITING Alicante Spain Details
Hospital Del Mar RECRUITING Barcelona Spain Details
Hospital Quiron Dexeus RECRUITING Barcelona Spain Details
START Barcelona - HM Nou Delfos RECRUITING Barcelona Spain Details
START Rioja - Hospital de San Pedro RECRUITING Logroño Spain Details
Hospital Regional Universitario de Malaga - General Hospital RECRUITING Málaga Spain Details
Hospital Universitario Morales Meseguer RECRUITING Murcia 30008 Spain Details
Hospital Universitario Infanta Sofía RECRUITING San Sebastián de los Reyes Spain Details
Hospital Universitario Virgen Del Rocío RECRUITING Seville Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field